Catherine Schulte
Stock Analyst at Baird
(4.81)
# 103
Out of 4,415 analysts
78
Total ratings
67.06%
Success rate
19.85%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Outperform | $73 → $81 | $77.29 | +4.80% | 3 | May 2, 2024 | |
| AVTR Avantor | Maintains: Outperform | $27 → $26 | $24.72 | +5.18% | 8 | Apr 29, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $621 → $620 | $572.38 | +8.32% | 20 | Apr 25, 2024 | |
| DHR Danaher | Maintains: Outperform | $259 → $271 | $248.38 | +9.11% | 4 | Apr 24, 2024 | |
| A Agilent Technologies | Maintains: Outperform | $140 → $130 | $139.45 | -6.78% | 10 | Nov 21, 2023 | |
| QGEN Qiagen | Initiates: Outperform | $52 | $42.98 | +19.82% | 1 | Sep 12, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $18 → $11 | $8.97 | +22.63% | 2 | Aug 8, 2023 | |
| EXAS Exact Sciences | Maintains: Outperform | $99 → $121 | $62.07 | +94.94% | 10 | Aug 2, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,454 → $1,366 | $1,251.95 | +9.11% | 4 | Jul 28, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $24.33 | +56.19% | 4 | Mar 1, 2023 | |
| TWST Twist Bioscience | Maintains: Outperform | $56 → $33 | $41.21 | -19.92% | 2 | Nov 21, 2022 | |
| ILMN Illumina | Downgrades: Neutral | n/a | $117.93 | - | 4 | Apr 21, 2020 | |
| WAT Waters | Downgrades: Neutral | n/a | $321.25 | - | 5 | Jan 24, 2019 | |
| NTRA Natera | Maintains: Outperform | n/a | $96.98 | - | 1 | Jun 28, 2018 |
Bio-Techne
May 2, 2024
Maintains: Outperform
Price Target: $73 → $81
Current: $77.29
Upside: +4.80%
Avantor
Apr 29, 2024
Maintains: Outperform
Price Target: $27 → $26
Current: $24.72
Upside: +5.18%
Thermo Fisher
Apr 25, 2024
Maintains: Outperform
Price Target: $621 → $620
Current: $572.38
Upside: +8.32%
Danaher
Apr 24, 2024
Maintains: Outperform
Price Target: $259 → $271
Current: $248.38
Upside: +9.11%
Agilent Technologies
Nov 21, 2023
Maintains: Outperform
Price Target: $140 → $130
Current: $139.45
Upside: -6.78%
Qiagen
Sep 12, 2023
Initiates: Outperform
Price Target: $52
Current: $42.98
Upside: +19.82%
Maravai LifeSciences Holdings
Aug 8, 2023
Maintains: Outperform
Price Target: $18 → $11
Current: $8.97
Upside: +22.63%
Exact Sciences
Aug 2, 2023
Maintains: Outperform
Price Target: $99 → $121
Current: $62.07
Upside: +94.94%
Mettler-Toledo International
Jul 28, 2023
Maintains: Neutral
Price Target: $1,454 → $1,366
Current: $1,251.95
Upside: +9.11%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $24.33
Upside: +56.19%
Twist Bioscience
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $41.21
Upside: -19.92%
Illumina
Apr 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $117.93
Upside: -
Waters
Jan 24, 2019
Downgrades: Neutral
Price Target: n/a
Current: $321.25
Upside: -
Natera
Jun 28, 2018
Maintains: Outperform
Price Target: n/a
Current: $96.98
Upside: -